BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12958347)

  • 1. Immunology. Hide and seek in the peptidome.
    Yewdell JW
    Science; 2003 Sep; 301(5638):1334-5. PubMed ID: 12958347
    [No Abstract]   [Full Text] [Related]  

  • 2. Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1.
    Yin Y; Manoury B; Fåhraeus R
    Science; 2003 Sep; 301(5638):1371-4. PubMed ID: 12958359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology. Nothing 'gainst time's scythe can make defense..
    Ploegh HL
    Science; 2004 May; 304(5675):1262-3. PubMed ID: 15166355
    [No Abstract]   [Full Text] [Related]  

  • 4. Epstein-Barr virus: exploiting the immune system by interfering with defective ribosomal products.
    Apcher S; Fahraeus R; Manoury B
    Microbes Infect; 2004 Nov; 6(13):1212-8. PubMed ID: 15488741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus.
    Lautscham G; Rickinson A; Blake N
    Microbes Infect; 2003 Apr; 5(4):291-9. PubMed ID: 12706442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avoiding proteasomal processing: the case of EBNA1.
    Dantuma NP; Sharipo A; Masucci MG
    Curr Top Microbiol Immunol; 2002; 269():23-36. PubMed ID: 12224511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology: professional secrets.
    Roy CR
    Nature; 2003 Sep; 425(6956):351-2. PubMed ID: 14508466
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.
    Levitskaya J; Sharipo A; Leonchiks A; Ciechanover A; Masucci MG
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12616-21. PubMed ID: 9356498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune surveillance obstructed by viral mRNA.
    Starck SR; Cardinaud S; Shastri N
    Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9135-6. PubMed ID: 18599434
    [No Abstract]   [Full Text] [Related]  

  • 10. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generating MHC class I ligands from viral gene products.
    Yewdell J; Antón LC; Bacik I; Schubert U; Snyder HL; Bennink JR
    Immunol Rev; 1999 Dec; 172():97-108. PubMed ID: 10631940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat sequence of Epstein-Barr virus-encoded nuclear antigen 1 protein interrupts proteasome substrate processing.
    Zhang M; Coffino P
    J Biol Chem; 2004 Mar; 279(10):8635-41. PubMed ID: 14688254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological functions of the proteasome.
    Niedermann G
    Curr Top Microbiol Immunol; 2002; 268():91-136. PubMed ID: 12083010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus and the immune system. Hide and seek.
    Cohen JI
    JAMA; 1997 Aug; 278(6):510-3. PubMed ID: 9256227
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advance in the study on the proteasome activator PA28].
    Murata S; Chiba T
    Tanpakushitsu Kakusan Koso; 2000 Aug; 45(11):1832-40. PubMed ID: 10936967
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitating protein synthesis, degradation, and endogenous antigen processing.
    Princiotta MF; Finzi D; Qian SB; Gibbs J; Schuchmann S; Buttgereit F; Bennink JR; Yewdell JW
    Immunity; 2003 Mar; 18(3):343-54. PubMed ID: 12648452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.
    Guermonprez P; Saveanu L; Kleijmeer M; Davoust J; Van Endert P; Amigorena S
    Nature; 2003 Sep; 425(6956):397-402. PubMed ID: 14508489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To DRiP or not to DRiP: generating peptide ligands for MHC class I molecules from biosynthesized proteins.
    Yewdell J
    Mol Immunol; 2002 Oct; 39(3-4):139-46. PubMed ID: 12200046
    [No Abstract]   [Full Text] [Related]  

  • 19. How do endogenous proteins become peptides and reach the endoplasmic reticulum.
    Nandi D; Marusina K; Monaco JJ
    Curr Top Microbiol Immunol; 1998; 232():15-47. PubMed ID: 9557392
    [No Abstract]   [Full Text] [Related]  

  • 20. Lessons from an age-old war.
    Powis SH
    Nat Med; 1998 Aug; 4(8):887-8. PubMed ID: 9701231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.